Prosecution Insights
Last updated: October 04, 2026

NV Medtech Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

NV Medtech Inc. currently has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This portfolio of 1 pending action reflects the company's active effort to secure patent rights for its medical and mechanical innovations. The focus on Medical Devices & Mechanical Engineering is the primary area of activity for its current filing within the patent office, showing a targeted approach to intellectual property.

The prosecution is handled by 1 distinct examiner and 1 distinct art unit. Since there is only 1 pending office action, the entire workload is concentrated within a single specialized department of the patent office. This alignment suggests that the company's current technological focus is highly specific and falls under the jurisdiction of one examination group, which simplifies the tracking of procedural requirements and examiner expectations.

FISHBACK, ASHLEY LAUREN is the busiest examiner for the portfolio, with 1 busiest examiner pending action. Because the busiest examiner pending count is 1 and there is only 1 total pending office action, FISHBACK, ASHLEY LAUREN is responsible for the company's entire pending workload. This centralized structure means that the outcome of the company's current prosecution effort is entirely dependent on the review of this single examiner, allowing for a focused legal strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FISHBACK, ASHLEY LAUREN 1 80.1% +21.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19572852 INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS FISHBACK, ASHLEY LAUREN —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19572852 INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS FISHBACK, ASHLEY LAUREN —

Top Art Units

Art UnitApps
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19572852 INTRAVASCULAR FLOW DIVERTER AND RELATED METHODS FISHBACK, ASHLEY LAUREN 3771 §112 Non-Final OA — Pending Mar 19, 2026

Managing NV Medtech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month